Class of drug | Drug name | Cancer sites | Common toxicity |
---|---|---|---|
Alkylating agents | Carboplatin | Ovarian and small cell lung cancers, germ cell tumours | Ototoxicity, myelosuppression |
Cisplatin | Testicular, lung, cervical, bladder, head and neck, and ovarian cancers | Nephrotoxicity, myelosuppression | |
Ifosfamide | Germ cell tumours | Urothelial toxicity, myelosuppression | |
Lomustine | Hodgkin's, malignant melanoma, glioblastoma multiforme and neuroendocrine tumours | Myelosuppression | |
Temozolomide | Glioblastoma multiforme and malignant glioma | Hepatotoxicity, myelodysplastic syndromes, secondary malignancy, myelosuppression | |
Antimetabolites | 5-Fluorouracil, capecitabine | Gastrointestinal and breast cancers | Patients with DPD deficiency are at increased risk of severe and fatal toxicity, cardiotoxicity, myelosuppression |
Gemcitabine | Non-small cell lung cancer, pancreatic, bladder, ovarian and breast cancers | Myelosuppression | |
Pemetrexed | Mesothelioma and non-small cell lung cancer | Myelosuppression | |
Raltitrexed | Colorectal cancer | Myelosuppression | |
Antitumor antibiotic | Doxorubicin | Ovarian and breast cancers | Cardiotoxicity, myelosuppression |
Epirubicin | Breast, gastric, small cell lung, ovarian and colorectal cancers | Chemical cystitis, myelosuppression | |
Bleomycin | Germ cell tumours | Pulmonary toxicity, myelosuppression | |
Topoisomerase inhibitors | Irinotecan | Colorectal cancer | Thromboembolism, interstitial lung disease, myelosuppression |
Etoposide | Small cell lung cancer and germ cell tumours | Myelosuppression | |
Mitotic inhibitors | Docetaxel | Breast, non-small cell lung cancer, gastric, head and neck, and prostate cancers | Myelosuppression, hepatotoxicity |
Eribulin | Breast | Myelosuppression | |
Paclitaxel | Breast, ovarian, non-small cell lung cancer and pancreatic cancers | Cardiotoxicity, interstitial lung disease, myelosuppression | |
Vincristine, vinorelbine | Breast and lung cancers | Myelosuppression, peripheral neuropathy | |
Glucocorticoids | Prednisolone, dexamethasone | Multiple tumour types | Adrenal insufficiency, weight gain, hyperglycaemia |
DPD = dihydropyrimidine dehydrogenase.